Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aditxt, Inc.
Richmond, Virginia, USAaditxt.com ↗
- Ownership
- Public · ADTX
- Employees
- ~26
- Development stage
- Other
01
Overview
Aditxt has completed all preclinical studies on its lead therapeutic candidate ADI‑100 with positive safety and efficacy data in autoimmune models including type I diabetes and psoriasis. The company’s diagnostic programs are commercially available or near-commercialization. First-in-human clinical trials are planned or underway in Germany and the U.S., targeting autoimmune diseases such as psoriasis, T1D, and Stiff Person Syndrome.
- Therapeutic areas
- DermatologyImmunologyEndocrinologyNeurology
- Modalities
- Nucleic acid-based immunotherapy (Apoptotic DNA Immunotherapy™/ADi™)Immune monitoring diagnosticsEEG brain monitoring devices
- Industry
- Biotech
02
Partnerships
Loma Linda University license agreementStanford University license agreement
03
Financials
- Market cap
- $7.8M
- Total revenue
- $12.2K
- Enterprise value
- $11.7M
Beyond the preview
Go deeper on Aditxt, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aditxt, Inc..